Anhedonia in schizophrenia: The role of subjective experiences by Fortunati, Renata et al.
Anhedonia in schizophrenia: The role of subjective experiences
Renata Fortunatia,b, Paolo Ossolaa,b, Annalisa Camerlengoa, Elena Bettinia,
Chiara De Panfilisa,b, Matteo Tonnab, Carlo Magginia, Carlo Marchesia,b,⁎
aUnit of Psychiatry, Department of Neuroscience, University of Parma, University Hospital, Braga Building, via Gramsci, 14, 43126, Parma, Italy
bMental Health Department, Local Health Agency, University Hospital, Braga Building, via Gramsci, 14, 43126 Parma, Italy
Abstract
Background: High levels of anhedonia have been found in patients with schizophrenia; specifically they report higher levels of social
anhedonia rather than physical anhedonia, and further, in the anticipatory rather than consummatory facets of pleasure. Nonetheless,
contrasting results emerged regarding the underlying mechanisms of this deficit. Basic Symptoms (BS) disturb subjective experiences present
for most of the illness’ course; this impacts patients’ daily lives leading to a loss of the ability to organize the experience of the self and the
world in a fluid and automatic way. Considering the role played by negative emotions in the subjective evaluation of anhedonia, the aim of
the study is to clarify the role of BS in the assessment of anhedonia in a sample of patients with schizophrenia (n = 53) compared with
healthy controls (n = 46).
Methods: Participants completed a self-administered trait questionnaire evaluating social anhedonia (Revised-Social Anhedonia Scale),
physical anhedonia (Physical Anhedonia Scale), and the consummatory and anticipatory pleasure experiences (Temporal Experience of
Pleasure Scale). BS were evaluated with the Frankfurter Beschwerde-Frageboden (FBF) whereas psychopathology was assessed with the
Positive and Negative Syndromes Scale.
Results: Patients scored higher than healthy controls in social, physical and anticipatory anhedonia, but not in consummatory anhedonia and
these relationships were mediated by the FBF. Basic Symptoms of Memory, Overstimulation and Lack of Automatism were related to some
facets of anhedonia, independently from depressive symptoms.
Conclusions: We hypothesize that a subjective cognitive deficit and a reduced ability in information processing, could prevent patients from
retaining a positive experience from past pleasant activities. Therefore the lack of pleasure would be, at least in part, related to an avoidance
of potentially stressful new scenarios.
© 2015 Elsevier Inc. All rights reserved.
1. Introduction
The first descriptions of the “failure in the ability to
experience pleasure” date back to the XIX century [1–3], but
it was the French psychologist Ribot [4] that, in 1896, coined
the term anhedonia, in contrast to analgesia, to describe the
inability to experience pleasure. The multiple meanings of
anhedonia in literature reflect the ambiguous definition of
pleasure and the fact that pleasure has always been
associated with seeking behaviors [5]. The evaluation of
hedonic ability in psychiatry considered both the nature of
the stimulus (i.e. physical or social) and the reward-related
mechanisms (i.e. wanting or liking) [6–9]. Moreover,
pleasure associated with future events could be divided
into anticipated (i.e. pleasure expected to be experienced in
the future) and anticipatory (i.e. pleasure experienced in
the immediate present, imagining future events) [10].
Cognitive mechanism may be involved in anticipated
pleasure whereas the anticipatory one relies more on
emotional features [11,12].
The first time that the word anhedonia appeared was
within a description of Schizophrenia by Pascal [13],
although an impairment in the ability to experience pleasure
has always been associated with Kraepelin [14] and
Bleuler’s [15] description of schizophrenia and specifically
with the affective flattening. Its role as a distinctive
characteristic of schizophrenia was initially hypothesized
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by Myerson [16], but it is only with Rado [17] and Meehl
[18] that it acquires a central position in the pathogenesis of
the disorder.
Most of the studies observed higher levels of anhedonia in
patients with schizophrenia, specifically for social rather
than physical experiences [19,20], compared to healthy
subjects [21–27]. Furthermore, literature agrees that ‘want-
ing’, more than ‘liking’, is impaired in Schizophrenia
[28–31] even in the early phases of the disorder [32]. A
limitation of these studies evaluating anhedonia in patients
with schizophrenia is the method of its assessment. On the
one hand, some of the scales used (i.e. the Anhedonia–
Asociality subscale of the Scale for the Assessment of
Negative Symptoms, SANS and the Passive/apathetic social
withdrawal score at Positive and Negative Syndromes Scale,
PANSS) [33,34] chiefly evaluate the behavioral facets of
anhedonia, relying on the assumption that the reduction of
involvement in pleasant stimuli reflects only an emotional
disturbance [35], although anergia, abulia, social anxiety and
intentional avoidance of stressful situations could reduce
engagement in pleasant situations [36–39].
On the other hand, self-report trait questionnaires (e.g. the
Revised-Social Anhedonia Scale, R-SAS; the Physical
Anhedonia Scale, PAS; the Temporal Experience of Pleasure
Scale, TEPS; and the Snaith Hamilton Pleasure Scale,
SHAPS) [40–43] aimed at measuring a more subjective
anhedonia, do not capture how some negative emotions
affect the patients’ score [44,45].
Moreover, in patients with schizophrenia, a discrepancy
has been observed between the ability to experience pleasure
as assessed by questionnaires (i.e. expressive anhedonia) and
that reported in laboratory studies and via experience
sampling method (i.e. experiential anhedonia). In fact, levels
of positive emotion were similar to those of healthy subjects
when providing reports of current feelings, but lower when
reporting their noncurrent feelings through representative or
retrospective interviews [12,45,46]. Remarkably, in the
evaluation of current feelings, patients with schizophrenia
showed higher levels of negative emotions [35,47] anyway.
A peculiar dimension of schizophrenic psychopathology
that, by definition, is associated with negative emotions, is
the subtle experienced disturbances in drive, affect, thinking,
speech, (body) perception, motor action, central vegetative
functions and stress tolerance [48]. Patients with schizo-
phrenia experience these disturbing subjective symptoms for
most of the illness’ course [48].
The first detailed investigations of patient subjective
experience in schizophrenia began in the 50s with the studies
by Chapman [49] and Huber [50], the latter on the basis of
Süllwold’s observations on motor disorders [51].
Among these experiences, the most studied are Basic
Symptoms: uncharacteristic elementary experiences, con-
fined to the subjective sphere, that are “not behavioural, but
experiential in kind” [52] and are the manifestation of
disorders in information processing [53] and considered the
direct consequence of the neuropathological defect [49,54].
They are present in the pre-, intra- and post-psychotic phases
of the disorder.
Schneiderian’s first rank symptoms and Negative symp-
toms hail from these pre-existing disorders along a continuum
of psychopathological evolution as an interaction between the
personological matrix and coping mechanism [55].
A way in which patients could cope with basic symptoms
is the avoidance of new scenarios, which in turn, could evoke
them. This is reflected by an impairment in the subject’s
global functioning [53].
Basic Symptoms may therefore affect a patient’s ability to
anticipate pleasant events, recalling them and maintaining a
hedonic tone. This could result in ambivalent experiences
[56,47] that could in part justify the patients’ higher scores in
questionnaires assessing trait anhedonia.
The aim of the study is to evaluate whether patients with
schizophrenia are more anhedonic than healthy controls in
self-report trait questionnaires and if this relationship is
mediated by Basic Symptoms.
2. Materials and methods
2.1. Sample recruitment and procedure
The study sample was comprised of 53 patients with
schizophrenia recruited among the outpatients service in a
Community Mental Health Service and 46 healthy controls
(HCs). Exclusion criteria for study participation were: 1)
being younger than 18 or older than 65 years old; 2)
cognitive impairment (MMSE b25) [57] or language barriers
interfering with the capacity to reliably answer diagnostic
interviews or questionnaires; 3) evidence of substance use
disorder; 4) and in the HC group the presence of an axis I or
II diagnosis according to DSM-IV-TR diagnostic criteria.
After giving informed consent all patients were inter-
viewed by an expert psychiatrist (R.F.). The study protocol
has been approved by the relevant national and institutional
committees on human experimentation and according the
Helsinki Declaration of 1975, as revised in 2008.
2.2. Measures
2.2.1. Axis I and II pathology
Current psychiatric disorders were assessed with the
Structured Clinical Interview for DSM-IV Axis I disorders
Research Version (SCID-I/P-RV) [58].
Psychopathology severity was assessed by means of the
Positive and Negative Syndromes Scale (PANSS) [34] and,
in the patient group, depressive symptoms were evaluated
with the Calgary Depression Scale for Schizophrenia
(CDSS) [59]. PANSS consists of three different subscales:
positive, negative and general psychopathology. All partic-
ipants were clinically stable, being defined as no inpatient
hospitalization within three months of study participation; in
the same way, none of them underwent changes in therapy in
the aforementioned time interval. We adopted the CDSS,
rather than other instruments to assess depression because it
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showed the best divergent validity (i.e. most accurately
differentiated between depressive symptoms from other
symptoms of schizophrenia) [60].
In the HC group current depressive symptoms and
personality disorders were excluded with the Hamilton
Depression Rating Scale (HAM-D score b 8) [61] and with
the Structured Interview for DSM-IV Personality (SIDP-IV)
[62], respectively. HCs had no history of psychiatric disorder
(i.e. medication prescription, psychotherapy or previous
hospitalization); moreover they underwent a psychiatric
interview that excluded the presence of current and past
psychiatric disorders.
2.2.2. Anhedonia
All subjects completed the Physical Anhedonia Scale
(PAS) [40], Revised Social Anhedonia Scale (R-SAS) [41]
and the Snaith–Hamilton Pleasure Scale (SHAPS) [42].
Moreover, they filled out the Temporary Experience of
Pleasure Scale (TEPS) [43] that assesses the ability of
experiencing pleasure on two subscales, anticipatory and
consummatory, with lower scores reflecting higher levels
of anhedonia.
2.2.3. Subjective experiences
Subjective experiences have been evaluated with the
Italian version of the Frankfurt Complaint Questionnaire.
Several rating scales for measuring subjective experiences
have been published [63] and among these the Frankfurter
Beschwerde-Frageboden (FBF) [64], is one of the most
frequently used. It covers a great variety of cognitive
complaints involving attention, perception, memory, think-
ing, language, movement and emotions. FBF is a self-
administered 98-item true/false questionnaire that evaluates
the presence of Basic Symptoms and has been developed
from verbal statements originally made by patients with
schizophrenia. The latest version (the third) contains 98
items concerning a wide range of dysfunctions clustered in
10 subscales, these being: Loss of Control (KO), which
includes both volitional and cognitive aspects; Simple
Perception (WAS), which deals with possible sensorial
disturbances; Complex Perception (WAK), which involves
polysensorial perception (e.g. synesthesias); Language
Disorder (SP), which involves difficulties in both the
receptive and expressive facets of language; Thought
Disorder (DE), which refers to interference, barrages and
other impairment in the flow of thoughts; Memory (GED),
which refers to both short-term and more structured long-
term memory disturbances; Motility (MO), which evaluates
subtle disturbances in motor control or kinesthesias; Lack of
Automatization (AU), which explores the loss of some
automatic functions and the consequent need to reflect even
on some usually natural activities; Anhedonia–Anxiety
(AN), which includes several dynamic deficits in drive,
affect and emotional resonance; and finally, Overstimulation
(REI), which reflects the lower threshold of dealing with
stressful events, so that even daily activities could lead to
disturbing experiences.
Typical FBF items are as follows: “I’m not able to protect
myself sufficiently, everything has too much impact on me”
(item 89); “Doing simple daily tasks, I have to think carefully
about what comes first and what comes next” (item 38); “I
often notice that I cannot remember what I just said or just
did” (item 73); "I have many gaps in my memory; many
things I knew have disappeared" (item 8).
Subjective Experiences measured with the FBF have
shown to constitute a dimension that is independent and
distinct from other psychopathological dimensions [65] with
unidimensional psychometric properties [66] and high
internal consistency [67,68].
2.2.4. Global functioning
Global functioning in the whole sample has been assessed
with the Personal and Social Performance Scale (PSP) [69], a
clinician-administered measure, containing the four main
areas: socially useful activities, personal and social relation-
ships, self-care, aswell as disturbing and aggressive behaviour.
2.3. Statistical analyses
Internal consistency of TEPS has been calculated and a
partial confirmatory factor analysis (PCFA) [70] has been
performed on the Italian Version of TEPS [71], since to our
knowledge it has never been administered to a clinical sample.
We first assessed the normal distribution of variables
through the Kolmogorov–Smirnov test. CDSS (D = 0.193,
p = b.001), SHAPS (D = 0.262, p = b.001), TEPS con-
summatory subscale (D = 0.174, p = .001), R-SAS (D =
0.150, p = b.001) and PSP (D = 0.129, p = .033) were
non-normally distributed.
The internal consistency of the TEPS was acceptable in
the whole sample (Cronbach’s alpha = .802) and in the two
groups (Cronbach’s alpha in Healthy Controls = .806;
Cronbach’s alpha in Patient Group = .784) as much as its
subscales (Cronbach’s alpha for the Anticipatory subscale =
.700; Cronbach’s alpha for the Consummatory subscale =
.711). A lower alpha has been detected in the patient group
for the Anticipatory subscale (Cronbach’s alpha = .646).
The results of the partial confirmatory factor analysis
(PCFA) confirmed a two factor structure (KMO = .705;
Bartlett’s test of sphericity: p b .001; Good-fit-test: Chi-
squared = 165.14; df = 118; p = .003; CFI = 0.90;
RMSEA = 0.06).
The differences among groups were evaluated using
Student’s t test for continuous variables with a normal
distribution (i.e. age, scores at TEPS anticipatory subscale,
PAS) andwithMann–WhitneyU for non-normally distributed
values (i.e. CDSS, SHAPS, TEPS consummatory subscale,
R-SAS, PANSS and PSP) and χ2 for categorical variables
(i.e. gender, education, employment and living status).
Similarly Pearson’s and Spearman’s correlations have
been calculated, where appropriate, between the anhedonia
scales (PAS, R-SAS, TEPS Anticipatory and Consummatory
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subscales, SHAPS), subjective experiences (FBF) and global
functioning (PSP). The correlations between anhedonia
scores and general psychopathology (PANSS subscales,
CDSS) have been performed in the patient group only.
We next evaluated in the whole sample (n = 97) whether
subjective experiences (supposed mediator) mediate the
relationship between a diagnosis of Schizophrenia (indepen-
dent variable) and all the anhedonia scales (outcome variable)
using Hayes’ bootstrapping procedure for conditional effects
(SPSS PROCESS macro, Model #4) [72]. This procedure
makes no assumption about the normality of the data and is
more tolerant of a small sample size by utilizing 5000 bootstrap
resamples to estimate a 95%confidence interval for a particular
effect. We excluded from the mediation analysis the score at
the negative subscale of the PANSS, although significantly
different between the two groups, because its scores in the HC
were nil (mean = 7.00; SD = .00) and its items include to
some extent anhedonia. Furthermore, we did not consider
‘global functioning’ and ‘years of education’ as covariates as
they are almost implied in the diagnosis of Schizophrenia.
Analysis of covariance (ANCOVA with Bonferroni
correction), within the patient group, was used to evaluate
whether the difference in FBF subscales between anhedonics
and non-anhedonics at SHAPS, PAS and R-SAS remained
after controlling for the effect of state measures (i.e. CDSS).
Since a clear cut-off has not been established for the
Anticipatory subscale of TEPS, we performed a linear
regression (enter-method) to evaluate which FBF subscale
predicted anticipatory anhedonia (TEPS Anticipatory sub-
scale as dependent variable) controlling for depressive
symptoms (CDSS entered in the first block).
We carried out all the analysis using SPSS software
(version 20.0, IBM SPSS Statistics).
3. Results
3.1. Sample characteristic
Fifty-three patients with schizophrenia and 46 HCs
participated in the study. All the socio-demographic clinical
variables of the two groups are shown in Table 1.
In patients with schizophrenia the mean age at onset was
23.56 (sd = 5.77) and the mean duration of illness was 16.39
(sd = 9.84). They received a diagnosis of Paranoid (n = 40;
75.5%), Disorganized (n = 5; 9.4%) or Undifferentiated
(n = 8; 15.1%) Schizophrenia. Twenty-five patients were
taking an FGA (47.2%), 26 an SGA (49%) and two (3.8%) a
combination of an FGA and a SGA.
In the HC group the mean score at HAM-D was 0.57
(sd = 1.51) whereas in the patient group the mean CDSS
score was 2.68 (sd = 3.16).
3.2. Anhedonia
The only clinical variable in which patients with
schizophrenia did not score differently from HCs was the
consummatory subscale of the TEPS, confirming higher
anhedonia levels in the patient group and specifically as
lower anticipatory pleasure.
TEPS subscales strongly correlated with the other
anhedonia scales, global functioning and, within the patient
group only, with the negative symptoms at PANSS
(Table 2).
Differences between male and female have been found for
TEPS consummatory subscale (male = 4.36 ± .87; fe-
male = 4.82 ± .87; U = 815; z = −2.67; p = .008), specif-
ically in the HC group (male = 4.34 ± .84; female = 5.06 ±
.62; U = 133; z = −2.89; p = .003), and for SHAPS
(male = 1.5 ± 2.42; female = .84 ± 1.85; U = 892.5;
z = −2.36; p = .018). Age correlated significantly with
TEPS anticipatory subscale only (ρ = −.218; p = .031).
3.3. Predictors of anhedonia
In the whole sample the Mediation Analysis (model #4)
showed a significant indirect effect of Schizophrenia on
Anhedonia (i.e. SHAPS, TEPS Anticipatory Subscale,
R-SAS and PAS) through subjective experiences as
measured at FBF total score with a relatively strong effect
across different scales (18%–27%) (Fig. 1).
Spearman correlations between the FBF subscales and the
four aforementioned anhedonia scales were always signifi-
cant; nonetheless, the highest values have been found
between ‘PAS’ and ‘R-SAS’ with ‘FBF Overstimulation’
(PAS: ρ = .506; p b .001; R-SAS: ρ = .595; p b .001) and
then between ‘SHAPS’ and ‘TEPS anticipatory subscale’
with ‘FBF Memory’ (SHAPS: ρ = .461; p b .001; TEPS
Anticipatory Subscale ρ = −.366; p b .001).
We then divided the patient group into anhedonics and
non-anhedonics, according to each scale cut-off (SHAPS:
cut off = 3; R-SAS: cut off = 12; PAS: cut off = 18)
[40–42,73]. The mean score at the negative subscale of
PANSS in the two groups was not significantly different,
confirming previous results [26] and supporting the bimodal
distribution of anhedonia in schizophrenia [74].
Differences in FBF subscales have then been computed
with the abovementioned dichotomization co-varying for
the CDSS (Table 3). The differences between the two
groups (anhedonics vs non-anhedonics) remained significant
for FBF Memory according to SHAPS cut-off and for
FBF Overstimulation, Lack of Automatism and Anhedonia–
Anxiety subscales according R-SAS cut-off, suggesting amore
stable (trait) effect of these dimensions on Anhedonia scales.
At the linear regression no FBF subscale predicted the
TEPS anticipatory score after controlling for CDSS.
4. Discussion
In this study, we evaluated the anhedonic features in a
sample of patients with schizophrenia matched with a group
of healthy controls.
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Patients resulted more anhedonic than healthy controls in
physical, social and anticipatory anhedonia, confirming
previous results [19–32]. The higher anhedonia levels in
the schizophrenic group were mediated by subjective
experiences (FBF total score) suggesting a role of Basic
Symptoms in the hedonic process. The fact that the
relationship between a diagnosis of schizophrenia and
anhedonia was explained by Basic Symptoms could mean
that, although healthy subjects could manifest a lack of
pleasure, only in the Schizophrenic sample was this
deficiency partly due to Basic Symptoms.
We found an inverse correlation between age and only
one of the pleasure scales (i.e. TEPS-anticipatory). We are
Table 1
Sociodemographic and clinical characteristic of patients and healthy controls.
Patients Healthy Controls p
n = 53 n = 46
Sex (M) 32 (60.4%) 23 (50.0%) χ2 = 1.0 p = .30
Age (years) 40.1 ± 10.5 38.3 ± 10.5 t = .8 p = .39
Years of education 12.3 ± 3.7 14.1 ± 2.3 t = 2.8 p = .006
Employed 30 (56.6%) 39 (84.8%) χ2 = 11.4 p = .003
Married 4 (7.5%) 22 (47.8%) χ2 = 20.6 p = .001
CDSS 2.68 ± 3.16 –
HAM-D – 0.57 ± 1.51
TEPS-A 3.96 ± 0.81 4.53 ± 0.71 t = 3.65 p b .001
TEPS-C 4.45 ± 0.96 4.68 ± 0.78 U = 1032.5 z = −1.17 p = .244
PAS 19.94 ± 9.582 12.57 ± 7.311 t = −4.24 p b .001
R-SAS 13.96 ± 6.77 8.67 ± 5.453 U = 636.5 z = −3.99 p b .001
SHAPS 1.8 ± 2.72 0.52 ± 1.04 U = 834.0 z = −2.89 p = .004
PANSS tot 78.54 ± 19 30.8 ± 1.42 U = 0.00 z = −8.69 p b .001
PANSS Neg 21.88 ± 7.14 7 ± 0 U = 0.00 z = −9.02 p b .001
PANSS Pos 16.98 ± 5.75 7.06 ± 0.44 U = 4.0 z = −8.96 p b .001
PANSS Gen 39.79 ± 9.69 16.76 ± 1.35 U = 2.5 z = −8.67 p b .001
FBF Total Score 29.1 ± 21.7 5.48 ± 6.31 U = 350.5 z = −5.95
PSP 44.21 ± 15.63 80.65 ± 5.26 U = 19.5 z = −8.40 p b .001
TEPS-A = Anticipatory subscale of the Temporal Experience of Pleasure Scale; TEPS-C = Consummatory subscale of the Temporal Experience of Pleasure
Scale; PAS = Physical Anhedonia Scale; R-SAS = Revised-Social Anhedonia Scale; SHAPS = Snaith–Hamilton Pleasure Scale; PANSS tot = total score at
Positive and Negative Syndromes Scale; PANSS Neg = Negative subscale at Positive and Negative Syndromes Scale; PANSS Pos = Positive subscale at




PAS R-SAS SHAPS TEPS-A TEPS-C
PAS 1
R-SAS .629⁎⁎ 1
SHAPS .620⁎⁎ .466⁎⁎ 1
TEPS-A −.657⁎⁎,b −.410⁎⁎ −.515⁎⁎ 1
TEPS-C −.589⁎⁎ −.297⁎⁎ −.416⁎⁎ .552⁎⁎ 1
PSP −.428⁎⁎ −.440⁎⁎ −.284⁎⁎ .417⁎⁎ .132
FBF .484⁎⁎ .604⁎⁎ .453⁎⁎ −.413⁎⁎ −.189
PANSS-Tot a .504⁎⁎ .393⁎⁎ .292⁎ −.353⁎ −.281⁎
PANSS-Neg a .529⁎⁎ .380⁎⁎ .274⁎ −.372⁎⁎ −.329⁎
PANSS-Pos a .318⁎ 294⁎ .141 −.219 −.117
PANSS-Gen a .403⁎⁎ .299⁎ .305⁎ −.312⁎ −.249
CDSS a .116 .241 .233 −.175 −.056
PAS = Physical Anhedonia Scale; R-SAS = Revised-Social Anhedonia
Scale; SHAPS = Snaith–Hamilton Pleasure Scale; TEPS-A = Anticipatory
subscale of the Temporal Experience of Pleasure Scale; TEPS-C
Consummatory subscale of the Temporal Experience of Pleasure Scale;
PSP = Personal and Social Performance Scale. FBF = Frankfurter Beschwerde-
Frageboden total score. PANSS tot = total score at Positive and Negative
Syndromes Scale; PANSS Neg = Negative subscale at Positive and Negative
Syndromes Scale.
a Spearman’s correlation calculated in the patient group only.
b Pearson’s correlation.
⁎ p b .05.
⁎⁎ p b .001.
Fig. 1. Mediation of subjective experiences on anticipatory anhedonia in
patients with schizophrenia. c = indirect effect. c’ = direct effect. Note:
Level of Subjective Experiences, as Basic Symptoms at Frankfurter
Beschwerde-Frageboden (FBF) mediating the relationship between a
diagnosis of Schizophrenia and all the Scales evaluating Anhedonia
(lower scores at TEPS Anticipatory correspond to higher anhedonia levels).
Path values correspond to standardized coefficients from the causal steps
procedure. *TEPS Anticipatory: a = 23.62, p b .001; b = −0.14, p = .004;
c = −3.40, CI [−6.12, −1.10]; c’ = −2.29, p = .20; κ2 = .18, 95% BCa CI
[.06, .29]. Age as a covariate. *R-SAS: a = 23.62, p b .001; b = 0.17,
p b .001; c = 4.00, CI [2.07, 6.32]; c’ = 1.36, p = .34; κ2 = .27, 95% BCa CI
[.14, .39]. * PAS: a = 23.62, p b .001; b = 0.21, p = .001; c = 4.87, CI [2.27,
8.74]; c’ = −2.59, p = .20; κ2 = .23, 95% BCa CI [.13, .36]. *SHAPS: a =
23.62, p b .001; b = 0.04, p b .001; c = 1.06, CI [0.27, 2.06]; c’ = .26, p =
.61; κ2 = .20, 95% BCa CI [.06, .34]. Gender as a covariate.
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not aware of previous results in literature confirming or
disconfirming our finding, therefore we can only suppose
that there is an effect of a long lasting illness, since we found
a high correlation even between duration of illness and TEPS
anticipatory (r = −.378; p b .001). At present, our small
sample size does not allow us to infer a grounded-conclusion
regarding this result.
Moreover, we found males being more anhedonic than
females and specifically in the consummatory subscale of
TEPS, in which patients and control did not differ. This
result confirms the gender differences in anhedonia levels
found in healthy subjects [75].
Despite the correlation between negative symptoms and
scores in the anhedonia scales, we found a similar amount of
negative symptoms in the schizophrenic patients, split into
anhedonic and non-anhedonic. This finding confirms
previous results in the literature that found anhedonia to be
independent from negative symptoms [26,74,76–79] and
could reflect the ability of these scales (i.e. SHAPS, TEPS,
SAS and PAS) to measure a more subjective anhedonia,
which does not necessarily lead to behavioral disorders, as
measured by the PANSS negative subscale.
The correlation between global functioning and anhedo-
nia confirms previous results in literature [80–82,24].
To our knowledge, this is the first study to observe that
individuals with significant levels of anhedonia, not related
to depressive symptoms, show specifically higher basic
symptoms concerning Memory, Overstimulation, and Lack
of Automatism.
No correlation has been found between the anhedonia
scores and depressive symptoms; nonetheless, in order to
exclude a depressive component we compared Basic
Symptoms between Anhedonics and non-anhedonics adjust-
ing for depressive symptoms. Interestingly differences in all
the subscales of Basic Symptoms disappear for anticipatory
and physical pleasure, but remain a significant effect of some
subscales (i.e. Memory, Overstimulation, and Lack of
Automatism) on SHAPS and Social anhedonia. According
to our results the relationship between Basic Symptoms and
physical or anticipatory anhedonia was attributable to a state
depressive component (i.e. CDSS). Nonetheless, conclu-
sions based on a state facet should be drawn with precaution,
in fact CDSS mean score in the patient group was 2.68 ±
3.16, well under the suggested threshold (CDSS = 6) for a
depressive episode [83] and, despite the cross-sectional
design, the sample showed a relative clinical stability (≥3
months). In addition, the item #2 of CDSS (“How do you see
the future for yourself? Can you see any future?”) could
overlap at least partially with some items of the TEPS
Anticipatory Subscale anhedonia. Whereas SHAPS gauges a
more general inability to experience pleasure, it is possible
that social anhedonia (R-SAS) describes an anhedonia more
characteristic of schizophrenia [84] and related to disturbing
subjective experiences.
Basic Symptoms could in fact "contaminate" the experi-
ence of positive emotions, affecting the responses in self-report
questionnaires. Interestingly in support of this hypothesis,
FBF-Overstimulation was significantly related with Social
Anhedonia. In fact, according to the Basic Symptoms Model,
an excessive stimulation, which overwhelms the reduced
patients’ abilities in the information processing, increases the
emotional arousal turning potentially pleasant social activities
into negative and disturbing ones.
Moreover, FBF-Memory includes both short-term distur-
bances and more structured long-term disturbances (inability
to actualize past experiences in a way finalized and adequate
to daily situations). We can hypothesize that the short-term
deficits would lead patients to renounce those pleasures that
request a more preserved working memory (e.g. intellectual
pleasures such as reading a book, watching a movie),
whereas more structured disturbances in memory could
involve a loss of social and professional competence due to
the constant need of reconsidering and recollecting what was
implicit and acquired. This, along with the finding that social
anhedonic patients score higher on the loss of automatism
subscale of FBF, is conceptually close to the hyper-
reflexivity described by Sass and Parnas [85]. Patients,
therefore, have to deal with all activities, including those
previously experienced as pleasant [86], with considerable
effort due to concentration and subsequent stress [87].
This study has some limitations: 1) the small amount of
patients in the sample could limit the strength of the clinical
results; 2) the validity of self-report questionnaires on
anhedonia has been doubted by some authors, because
responding to hypothetical items presupposes a certain
ability in abstraction/mental representation and a preserved
retrieval memory that could be impaired in schizophrenia
[46]; 3) recently, the ability of TEPS in dissecting
anticipatory and consummatory pleasure has been ques-
tioned [88,89] and other factor solutions have been proposed
[75]. This being said, further longitudinal studies, with larger
sample sizes and the consideration of other measurement
techniques (i.e. neuropsychological and reward-related) are
needed to overcome the abovementioned limitations.
Table 3
Significant differences in FBF subscales dividing the patient group






F P Partial η2





FBF REI 4.03 ± 2.8 2.04 ± 2.6 5.76 .018 .111
FBF AN 4.30 ± 2.3 2.71 ± 2.2 5.77 .020 .107
FBF AU 4.74 ± 2.9 2.79 ± 2.6 5.12 .028 .096
SHAPS = Snaith–Hamilton Pleasure Scale; R-SAS = Revised-Social An-
hedonia Scale; FBF GED = Memory subscale of FBF; FBF REI =
Overstimulation subscale of FBF; FBF AN = Anhedonia–Anxiety subscale
of FBF; FBF AU = Lack of Automatism subscale of FBF.
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5. Conclusions
Altogether the results of this study suggest that Basic
Symptoms, and their emotional impact, could contribute to
the failure in the ability of reporting experienced pleasure
observed in patients with schizophrenia. Specifically,
Anhedonia measured with SHAPS, and Social Anhedonia,
which has been proposed as a trait-like feature in patients
with schizophrenia [90,84], were related to Basic Symptoms
independently from depressive symptoms. Our results are
close to those of Buck and colleagues [91] which, instead
evaluated the role of social cognition and metacognition in
anhedonia in Schizophrenia, according to which “anhedonia
may be linked with greater levels of reality distortion and
withdrawal.” These authors suggest that metacognition and
social cognition are necessary in order to make sense of and
regulate social interactions, where an “impairment in the
ability to ascribe mental states to others has been suggested
to lead to a sense of lack of attunement with others which
may then lead to social withdrawal and a dearth of rewarding
social experiences” [92]. Interestingly, in the Basic Symp-
toms model, cognitive deficit of memory, perception and
dynamic deficits would lead to the abovementioned “lack of
attunement” that in turn may contaminate pleasant
experiences.
Uncertainties and contrast arisen regarding the role of
anhedonia in Schizophrenia, are mirrored by its ambiguous
definition and marginal position within Schizophrenia
description: in fact, whereas the term anhedonia occurred
only as an associated feature in both DSM-III-R [93] and
DSM-IV [94] or DSM-IV-TR [95], it disappeared in DSM-5
[96]. This is partly confirmed by our results: considering the
primary nature of BS, anhedonia in patients with schizo-
phrenia could be seen as a secondary phenomenon reflecting
an ambivalence that has been central in early descriptions of
schizophrenia [15,18].
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